8 research outputs found
Javaslat a hazai mĂ©hnyakszƱrĂ©si eljĂĄrĂĄsrend korszerƱsĂtĂ©sĂ©re = Proposal for the modernization of cervical screening procedure in Hungary
Absztrakt:
Az Ășj mĂ©hnyakszƱrĂ©si irĂĄnyelv megalkotĂĄsĂĄban kĂ©t fontos szempont jĂĄtszott
szerepet. Az egyik az a bizonyĂtott tĂ©ny, hogy a mĂ©hnyakrĂĄk Ă©s rĂĄk elĆtti
ĂĄllapotok kialakulĂĄsĂĄban oki szerepet jĂĄtszik a humĂĄn papillomavĂrus magas
kockĂĄzatĂș törzsei okozta fertĆzĂ©s. A mĂĄsik a HPV-fertĆzĂ©s biolĂłgiai
viselkedĂ©sĂ©nek beĂ©pĂtĂ©se az Ășj szƱrĂ©si eljĂĄrĂĄsba. Az Ășj szƱrĂ©si eljĂĄrĂĄsnak hƱen
tĂŒkröznie kell a mĂ©hnyak karcinogenezisĂ©t. A szervezett, populĂĄciĂłszintƱ,
életkor-specifikus méhnyakszƱrés fokoznå az åtszƱrtségi arånyt, valamint a
szƱrés érzékenységének a fokozåsåval csökkenthetné az intervallumråkok szåmåt.
Orv Hetil. 2017; 158(52): 2062â2067.
|
Abstract:
Two main considerations played roles in creation of new cervical screening
system. One was the proven fact that high-risk human papilloma virus infection
plays a role in the development of cervical cancer and pre-cancerous lesions.
The other was the implementation of the HPV infectionâs biological behavior in
the new screening strategy. The new screening procedure faithfully reflects the
cervical carcinogenesis. An organised, population-based and age differentiated
screening method could increase attendance of screening and could decrease the
possibility of interval cancer rate due to increased sensitivity. Orv Hetil.
2017; 158(52): 2062â2067
A vĂ©dĆnĆi mĂ©hnyakszƱrĂ©si pilot program Ă©rtĂ©kelĂ©se | Assessment of the pilot program for cervical cancer screening by health visitors
Absztrakt:
Bevezetés: Az Európai Unió åltal tåmogatott
TĂMOP-6.1.3.A-13/1-2013-0001 program keretĂ©ben a vĂ©dĆnĆket szĂĄndĂ©koztunk bevonni
a szervezett méhnyakszƱrési programba. CélkitƱzés: A felmérés
elkĂ©szĂtĂ©sĂ©nek cĂ©lja Ă©rtĂ©kelni a mĂ©hnyakszƱrĂ©si kĂ©pzĂ©sre jelentkezĆ vĂ©dĆnĆk
elĂ©gedettsĂ©gĂ©t a felkĂ©szĂtĂ©s oktatĂłit Ă©s oktatĂĄsi segĂ©danyagait illetĆen,
tovĂĄbbĂĄ megĂĄllapĂtani, hogy a kapott ismeretek mennyiben feleltek meg
elvĂĄrĂĄsaiknak. MĂłdszer: A vĂ©dĆnĆk elĂ©gedettsĂ©gĂ©t kĂ©rdĆĂves
felméréssel, négy kérdéscsoport mentén vizsgåltuk: oktatók, oktatåsi segédanyag,
a tovĂĄbbkĂ©pzĂ©si nap Ă©rtĂ©kelĂ©se, a kĂ©pzĂ©s sorĂĄn kapott ismeretek megfelelĆsĂ©ge. A
kĂ©rdĆĂvek kitöltĂ©sĂ©nek idĆszaka: 2014. oktĂłberâdecember. Az összesĂtett adatok
Ă©rtĂ©kelĂ©se leĂrĂł statisztikai mĂłdszerrel törtĂ©nt. EredmĂ©nyek:
2148 vĂ©dĆnĆ adatait Ă©rtĂ©keltĂŒk, akik 5-ös skĂĄlĂĄn a szĂŒlĂ©sz-nĆgyĂłgyĂĄsz
szakemberek teljesĂtmĂ©nyĂ©t összessĂ©gĂ©ben 4,65, a vĂ©dĆnĆkĂ©t 4,61, a
nĂ©pegĂ©szsĂ©gĂŒgyi-szƱrĂ©si szakemberekĂ©t 4,56, az informatikai szakemberekĂ©t pedig
4,52 pontra Ă©rtĂ©keltĂ©k. A kĂ©pzĂ©s sorĂĄn ĂĄtadott oktatĂĄsi segĂ©danyag minĆsĂ©ge
98%-uk szĂĄmĂĄra hasznosĂthatĂł volt, a kapott ismeretek elvĂĄrĂĄsaiknak megfelelĆek
voltak. KövetkeztetĂ©s: A vĂ©dĆnĆk elĂ©gedettek voltak a pilot
program keretĂ©ben vĂ©gzett elmĂ©leti felkĂ©szĂtĆ oktatĂĄssal. A szakmailag jĂłl
felkĂ©szĂŒlt vĂ©dĆnĆk hozzĂĄjĂĄrulhatnak a mĂ©hnyakszƱrĂ©si program sikerĂ©hez. Orv.
Hetil., 2017, 158(12), 461â467.
|
Abstract:
Introduction: Within the tender (6.1.3.A-13/1-2013-0001)
supported by the European Union, we wished to involve health visitors into the
organized cervical cancer screening program. Aim: The aim of
our survey was to assess the satisfaction of health visitors, instructors, and
that of the teaching aids. Furthermore, we wished to assess whether the teaching
materials met the expectations. Method: Satisfaction of the
health visitors was assessed by a survey, in four groups of questions. These
involved the assessment of the instructors, the teaching aids, evaluation of the
further training day, and the compliance with the knowledge of training. Period
for completion of the questionnaires lasted from October to December in 2014. We
used descriptive statistics for data evaluation. Results: Data
of 2148 health visitors was evaluated. They rated the performance of
gynecologist-obstetricians 4.65, that of health visitors 4.61, that of public
health professionals 4.56, and that of IT specialists 4.52. 98% of the teaching
aids were useful for them and the acquired knowledge was appropriate with their
expectations. Conclusion: The health visitors were satisfied
with the theoretical instruction within the pilot program. The professionally
well prepared health visitors may contribute to the success of the cervical
cancer screening program. Orv. Hetil, 2017, 158(12),
461â467
The Value of a Novel Panel of Cervical Cancer Biomarkers for Triage of HPV Positive Patients and for Detecting Disease Progression.
In the era of primary vaccination against HPV and at the beginning of the low prevalence of cervical lesions, introduction of screening methods that can distinguish between low- and high-grade lesions is necessary in order to maintain the positive predictive value of screening. This case-control study included 562 women who attended cervical screening or were referred for colposcopy and 140 disease free controls, confirmed by histology and/or cytology. The cases were stratified by age. Using routine exfoliated liquid based cytological samples RT-PCR measurements of biomarker genes, high-risk HPV testing and liquid based cytology were performed and used to evaluate different testing protocols including sets of genes/tests with different test cut-offs for the diagnostic panels. Three new panels of cellular biomarkers for improved triage of hrHPV positive women (diagnostic panel) and for prognostic assessment of CIN lesions were proposed. The diagnostic panel (PIK3AP1, TP63 and DSG3) has the potential to distinguish cytologically normal hrHPV+ women from hrHPV+ women with CIN2+. The prognostic gene panels (KRT78, MUC5AC, BPIFB1 and CXCL13, TP63, DSG3) have the ability to differentiate hrHPV+ CIN1 and carcinoma cases. The diagnostic triage panel showed good likelihood ratios for all age groups. The panel showed age-unrelated performance and even better diagnostic value under age 30, a unique feature among the established cervical triage tests. The prognostic gene-panels demonstrated good discriminatory power and oncogenic, anti-oncogenic grouping of genes. The study highlights the potential for the gene expression panels to be used for diagnostic triage and lesion prognostics in cervical cancer screening